These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7684530)
21. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212 [TBL] [Abstract][Full Text] [Related]
22. [Chronic bacterial infection and echocardiographic parameters indicative of pulmonary hypertension in patients with cystic fibrosis]. Rovedder PM; Ziegler B; Pasin LR; Pinotti AF; Barreto SS; Dalcin Pde T J Bras Pneumol; 2008 Jul; 34(7):461-7. PubMed ID: 18695790 [TBL] [Abstract][Full Text] [Related]
27. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Tablan OC; Martone WJ; Doershuk CF; Stern RC; Thomassen MJ; Klinger JD; White JW; Carson LA; Jarvis WR Chest; 1987 Apr; 91(4):527-32. PubMed ID: 3829745 [TBL] [Abstract][Full Text] [Related]
28. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis]. Segonds C; Chabanon G Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673 [TBL] [Abstract][Full Text] [Related]
29. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727 [TBL] [Abstract][Full Text] [Related]
30. Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Muhdi K; Edenborough FP; Gumery L; O'Hickey S; Smith EG; Smith DL; Stableforth DE Thorax; 1996 Apr; 51(4):374-7. PubMed ID: 8733488 [TBL] [Abstract][Full Text] [Related]
31. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Elborn JS; Prescott RJ; Stack BH; Goodchild MC; Bates J; Pantin C; Ali N; Shale DJ; Crane M Thorax; 2000 May; 55(5):355-8. PubMed ID: 10770814 [TBL] [Abstract][Full Text] [Related]
32. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre. da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217 [TBL] [Abstract][Full Text] [Related]
33. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D; Stableforth D Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary transplantation for cystic fibrosis: pre-transplant recipient characteristics in patients dying of peri-operative sepsis. De Soyza A; Archer L; Wardle J; Parry G; Dark JH; Gould K; Corris PA J Heart Lung Transplant; 2003 Jul; 22(7):764-9. PubMed ID: 12873544 [TBL] [Abstract][Full Text] [Related]